Abstract Long bone abnormality (lbab/lbab) is a strain of dwarf mice. Recent studies revealed that the phenotype is caused by a spontaneous mutation in the Nppc gene, which encodes mouse C-type natriuretic peptide (CNP). In this study, we analyzed the chondrodysplastic skeletal phenotype of lbab/lbab mice. At birth, lbab/lbab mice are only slightly shorter than their wild-type littermates. Nevertheless, lbab/lbab mice do not undergo a growth spurt, and their final body and bone lengths are only *60% of those of wild-type mice. Histological analysis revealed that the growth plate in lbab/lbab mice, especially the hypertrophic chondrocyte layer, was significantly thinner than in wild-type mice. Overexpression of CNP in the cartilage of lbab/lbab mice restored their thinned growth plate, followed by the complete rescue of their impaired endochondral bone growth. Furthermore, the bone volume in lbab/lbab mouse was severely decreased and was recovered by CNP overexpression. On the other hand, the thickness of the growth plate of lbab/? mice was not different from that of wild-type mice; accordingly, impaired endochondral bone growth was not observed in lbab/? mice. In organ culture experiments, tibial explants from fetal lbab/lbab mice were significantly shorter than those from lbab/? mice and elongated by addition of 10 -7 M CNP to the same extent as lbab/? tibiae treated with the same dose of CNP. These results demonstrate that lbab/ lbab is a novel mouse model of chondrodysplasia caused by insufficient CNP action on endochondral ossification.
The skeletal phenotypes of these mutant mice resemble those of GC-B knockout mice. Furthermore, recent studies have elucidated that loss-of-function mutations in the human GC-B gene are the causes of acromesomelic dysplasia type Maroteaux (AMDM), one form of skeletal dysplasia with a disproportionate short stature phenotype [9] . The impaired skeletal growth phenotype observed in patients suffering from AMDM is similar to the skeletal phenotype of cn/cn, slw/slw, and GC-B knockout mice.
The long bone abnormality (lbab/lbab) mouse was first identified in The Jackson Laboratory (Bar Harbor, ME) as a spontaneous autosomal recessive mutant characterized by impaired growth of the long bones [10] . Recent studies have elucidated that the impaired growth of lbab/lbab mice is caused by a hypomorphic mutation in the CNP gene; Jiao et al. [11] found that its impaired growth phenotype is associated with a single point mutation in the mouse CNP gene, and we showed that this phenotype is completely recovered by CNP overexpression [12] . Yoder et al. [13] characterized the mutant CNP in lbab/lbab mice and demonstrated that it is less biologically active than authentic CNP; in whole-cell cGMP elevation and membrane guanylyl cyclase assays, 30-fold to greater than 100-fold more mutant CNP is required to activate GC-B compared to authentic CNP. We also confirmed that the mutant CNP in lbab/lbab mice retains only about 10% activity to induce cyclic GMP production through GC-B compared to authentic CNP in an in vitro transfection assay using COS-7 cells [12] . Collectively, lbab/lbab is a novel chondrodysplastic mouse model with insufficient CNP action on endochondral bone growth. Nevertheless, the skeletal phenotypes of lbab/lbab mice have only been partially described in short reports, including our own brief communication [11] [12] [13] , and have not yet been fully studied. In this study, we performed further analyses of the skeletal phenotypes of lbab/lbab mice.
Materials and Methods

Mice
Heterozygous (lbab/?) mice (C57BL/6 J background) were obtained from The Jackson Laboratory, and the strain was maintained by sib mating of heterozygotes. Transgenic mice with targeted overexpression of CNP in the growth plate chondrocytes under the control of the mouse proa 1 (II) (Col2a1) promoter (CNP-Tg) were created as reported previously [3] . To perform genetic rescue of lbab/ lbab mice, CNP-Tg mice were mated with lbab/? mice, and F 1 offspring heterozygous for the transgene and for the lbab allele were mated with those with only the lbab allele to generate lbab/lbab mice with the transgene expression (lbab/lbabÁCNP-Tg/? mice) [12] . Genotypes for the CNP transgene and the lbab allele were determined by PCR analysis using mouse genomic DNAs extracted from tails. Because there was no tendency of gender differences in the growth of each genotype (data not shown), we used only female mice in our experiments. Animal care and all experiments were conducted in accordance with the Guidelines for Animal Experiments of Kyoto University and were approved by the Animal Research Committee, Graduate School of Medicine, Kyoto University.
Skeletal Analysis
For 10 weeks after birth, body lengths of female mice were measured weekly. Body length was measured as the length from the nose to the anus (nasoanal length) or that from the nose to the tip of the tail (nose-tail length). Body weights were also measured weekly. Skeletal analysis was performed as previously described [14] . Briefly, mice were subjected to soft X-ray analysis (30 kVp, 5 mA for 1 min; Softron type SRO-M5; Softron, Tokyo, Japan), and lengths of the bones were measured on the X-ray films. CT scanning of the humerus was performed using a ScanXmate-L090 Scanner (Comscantechno, Yokohama, Japan). Three-dimensional microstructural image data were reconstructed and structural indices calculated using TRI/3D-BON software (RATOC System Engineering, Tokyo, Japan).
Histological Examination
Tibiae were fixed in 10% formalin neutral buffer, decalcified in 10% EDTA, and embedded in paraffin. Sections (5 lm thick) were sliced and stained with alcian blue (pH 2.5) and hematoxylin-eosin. For immunohistochemistry, sections were incubated with rabbit anti-type X collagen antibody (LSL, Tokyo, Japan), goat anti-Indian hedgehog (Ihh) antibody (Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-matrix metalloproteinase 13 (MMP-13) antibody (Thermo Fisher Scientific, Waltham, MA), and mouse anti-proliferating cell nuclear antigen (PCNA) antibody (Dako, Copenhagen, Denmark). Immunostaining was performed using the Histofine Mousestain Kit (Nichirei Biosciences, Tokyo, Japan) according to the manufacturer's instruction. Peroxidase activity was visualized using diaminobenzidine. Sections were counterstained with hematoxylin, dehydrated, and then mounted with malinol (Muto Pure Chemicals, Tokyo, Japan). To confirm antibody specificity, normal rabbit serum (SigmaAldrich, St. Louis, MO), normal goat IgG (Santa Cruz Biotechnology), and mouse IgG (Dako) were used as first antibodies for negative controls.
Organ Culture
Organ culture of fetal mouse tibiae or third metatarsi was performed as described previously [15] . Tibial or metatarsal explants from lbab/? mice and their lbab/lbab littermates at 16.5 days postcoitus were cultured for 4 days with vehicle or 10 -7 M CNP (Peptide Institute, Minoh, Japan). Medium was changed every day. Before and after the culture, the maximal longitudinal lengths of tibiae were measured as the total tibial length, the sum of the lengths of proximal and distal cartilaginous primordia (CP), and the length of the osteogenic center (OC), using a linear ocular scale mounted on an inverted microscope. For histological analysis, explants were fixed in 10% formalin neutral buffer and embedded in paraffin. Sections (5 lm thick) were sliced and stained with alcian blue (pH 2.5) and hematoxylin-eosin. Immunohistochemical staining of incorporated bromodeoxyuridine (BrdU) was performed using 5-Bromo-2 0 -deoxyuridine labeling and detection kit II (Roche Applied Science, Indianapolis, IN) according to the manufacturer's protocol.
Statistical Analysis
Data were expressed as the mean ± SEM. The statistical significance of differences between mean values was assessed using Student's t-test.
Results
Analyses of Skeletal Growth of lbab/lbab and lbab/? Mice As previously reported, lbab/lbab mice developed severe dwarfism characterized by short tails and extremities [11, 12] . At birth, lbab/lbab pups were slightly shorter than their wild-type littermates: the nasoanal and nose-tail lengths of lbab/lbab mice were 88 and 83% of those of (Fig. 1a , Supplemental Fig. 1 ).The ratios of nasoanal and nose-tail lengths of lbab/lbab mice to those of wild-type mice sharply decreased to 65% and 55%, respectively, by the age of 3 weeks. After 5 weeks of age, these ratios stabilized at 66-72% and 57-62%, respectively (Fig. 1a, Supplemental  Fig. 1 ). The body weight of lbab/lbab mice was 68% of that of their wild-type littermates at birth and decreased to 46% by the age of 3 weeks. The ratio did not increase until 5 weeks of age, becoming *60% after 7 weeks (Fig. 1b) . On the other hand, lbab/? mice were indistinguishable from their wild-type littermates at birth and grew almost similarly (Fig. 1a,b, Supplemental Fig. 1 ). Soft X-ray analysis revealed that longitudinal growth of the vertebrae, tail, and extremities was affected in lbab/lbab mice at the age of 2 weeks but was not affected in lbab/? mice (Fig. 1c) . Histological analysis revealed that at the age of 3 days the tibial growth plate, especially the hypertrophic chondrocyte layer, of lbab/lbab mice was apparently thinner than that of wild-type mice (Fig. 1d ). On the other hand, the thickness of the tibial growth plate of lbab/? mice was not different from that of wild-type mice (Fig. 1d) .
Effect of CNP Overexpression on Impaired Endochondral Bone Growth of lbab/lbab Mice
In order to further characterize the impaired skeletal growth of lbab/lbab mice, we analyzed how their impaired endochondral bone growth recovered in response to targeted overexpression of CNP in the cartilage in vivo [12] . We crossed lbab/lbab mice with cartilage-specific CNP transgenic mice under the control of type II collagen promoter (CNP-Tg mice) and obtained lbab/lbab mice with transgenic expression of CNP in cartilage (lbab/lbabÁCNP-Tg mice) [12] . At the first week after birth, the nasoanal length of lbab/lbabÁCNP-Tg mice was almost the same as that of lbab/lbab mice and considerably smaller than that of wild-type mice: nasoanal lengths of wild-type, lbab/lbab, and lbab/lbabÁCNP-Tg mice were 4.38 ± 0.06, 3.87 ± 0.37, and 4.00 ± 0.12 cm, respectively. Subsequently, lbab/lbabÁCNP-Tg mice began to grow larger than lbab/ lbab mice and promptly caught up with wild-type mice; although the nasoanal length of lbab/lbabÁCNP-Tg mice was still considerably smaller than that of wild-type mice until 3 weeks of age (5.70 ± 0.57 and 6.71 ± 0.10 cm, respectively, at age 3 weeks), it became almost comparable to that of wild-type mice after 4 weeks (7.38 ± 0.48 and 7.61 ± 0.10 cm, respectively, at age 4 weeks). Further, the body weight of lbab/lbabÁCNP-Tg mice was almost the same as that of lbab/lbab mice and smaller than that of wild-type mice until the age of 3 weeks but then promptly increased to a level comparable to that of wild-type mice (Supplemental Fig. 2) .
Soft X-ray analyses revealed that at the age of 2 weeks the impaired growth of bones formed through endochondral ossification in lbab/lbab mice was partially recovered by targeted overexpression of CNP in cartilage in lbab/ lbabÁCNP-Tg mice (Fig. 2a) : the recoveries in the longitudinal length of cranium and the lengths of the humerus, radius, ulna, femur, tibia, and vertebrae were 35, 73, 68, 37, 51, 63, and 27%, respectively (Fig. 2b) . Furthermore, at the age of 10 weeks, the impaired endochondral bone growth in lbab/lbab mice was almost completely recovered by targeted overexpression of CNP in cartilage, as observed in lbab/lbabÁCNP-Tg mice (Fig. 2c, d ). On the other hand, there were no significant differences in the width of the cranium, which is formed via intramembranous ossification, among the three genotypes at either 2 or 10 weeks (Fig. 2b, d ).
Histological analysis showed that the thickness of both the proliferative chondrocyte layer and the hypertrophic chondrocyte layer, positive for immunohistochemical staining for type X collagen, was significantly decreased in lbab/lbab mice compared to wild-type mice at the age of 2 weeks, as previously reported [12] (Fig. 3a, b) .The thinner proliferative chondrocyte layer in the lbab/lbab growth plate was completely recovered by targeted overexpression of CNP as observed in the lbab/lbabÁCNP-Tg growth plate (Fig. 3c) . The thinner hypertrophic chondrocyte layer in the lbab/lbab growth plate was also considerably recovered in the lbab/lbabÁCNP-Tg growth plate, although the extent of the recovery was less than in the proliferative chondrocyte layer (Fig. 3d) . Immunohistochemical staining for PCNA revealed that the number of PCNA-positive cells was severely decreased in the proliferative chondrocyte layer of the lbab/lbab growth plate (Fig. 3e) . The number of PCNA-positive cells did not recover in the proliferative chondrocyte layer of the lbab/ lbabÁCNP-Tg growth plate, whereas the thinner proliferative chondrocyte layer in the lbab/lbab growth plate was almost completely recovered in the lbab/lbabÁCNP-Tg growth plate (Fig. 3c) . The area positive for immunostaining of Ihh, one of the markers of hypertrophic differentiation, was decreased in the lbab/lbab growth plate compared to the wild-type growth plate (Fig. 3f) . The smaller size of the area positive for Ihh in the lbab/lbab growth plate was almost completely recovered in the lbab/ lbabÁCNP-Tg growth plate (Fig. 3f) . Immunohistochemical staining of MMP-13, a useful marker for terminal hypertrophic chondrocytes, was not changed between the three genotypes, indicating that the progression through the hypertrophy program was not accelerated in the lbab/lbab growth plate (Fig. 3g) .
At the age of 10 weeks, the tibial growth plate of lbab/ lbab mice continued to be thinner than that of wild-type mice and was completely recovered by overexpression of CNP in cartilage (Fig. 4) .
Recovery of Decreased Bone Volume in lbab/lbab
Mouse by CNP Overexpression Three-dimensional CT analysis manifested a marked reduction in bone volume of the humerus in lbab/lbab mice and considerable recovery in lbab/lbabÁCNP-Tg mice (Fig. 5) . At the age of 10 weeks, the quantified bone volume (BV/TV) and trabecular thickness (Tb.Th) of the humerus in lbab/lbab mice were 2.4% and 34.5 lm, whereas those in wild-type mice were 4.1% and 40.3 lm, respectively. The decreased BV/TV and Tb.Th in lbab/lbab mice were increased to 5.4% and 37.0 lm, respectively, in lbab/lbabÁCNP-Tg mice.
Organ Culture Experiments of Tibiae from lbab/lbab Mice
In order to further analyze the impaired endochondral ossification of lbab/lbab mice, we preformed organ culture experiments using tibial explants from fetal mice (Fig. 6a) [15] . Because skeletal phenotypes of mice heterozygous for the lbab allele were not different from those of wild-type mice, we compared the growth of tibial explants from lbab/lbab mice with that from lbab/? mice. At the beginning of culture, both the total length and the sum length of the CP of lbab/lbab tibiae were significantly smaller than those of lbab/? tibiae (3.80 ± 0.04 (Fig. 6b, c) . Tibial explants from lbab/lbab mice grew to the same extent as those from lbab/? mice during a 4-day culture period; the difference in the total length or in the length of the CP between lbab/lbab and lbab/? explants at the end of culture was comparable to that at the beginning of culture (Fig. 6b, c) . There was no significant difference in the length of the OC between the two genotypes before and after the culture period (data not shown). The treatment of CNP at the dose of 10 -7 M stimulated the growth of both lbab/lbab and lbab/? tibiae (Fig. 6b, c) . CNP stimulated the growth of lbab/lbab tibiae more potently than that of lbab/? tibiae; in the presence of 10 -7 M CNP, the difference between the total length of lbab/? tibiae and that of lbab/lbab tibiae was decreased (Fig. 6b) , and furthermore, the CP length of lbab/lbab tibiae became almost the same as that of lbab/? tibiae (Fig. 6c) . The growth of the OC was not stimulated by CNP in either lbab/lbab or lbab/? explants (data not shown).
Histological examination at the end of the culture period revealed that the length of the primordial growth plate (Fig. 7a) , especially that of the hypertrophic chondrocyte layer positive for type X collagen immunostaining (Fig. 7b,c) , was smaller in lbab/lbab explants than in Fig. 3 Histological analysis of tibial growth plates from 2-week-old wild-type (Wt), lbab/lbab, and lbab/lbabÁCNP-Tg mice. a Alcian blue and hematoxylin-eosin staining. Yellow bars (depicted as P) indicate proliferative chondrocyte layers, and red bars (depicted as H) indicate hypertrophic chondrocyte layers. b Immunohistochemical staining for type X collagen. Scale bar in a and b = 100 lm. Heights of the proliferative (c) and hypertrophic (d) chondrocyte layers. n = 3 each. *P \ 0.05, **P \ 0.01. e The proportion of PCNA-positive chondrocytes in proliferative chondrocyte layers. n = 3-4. **P \ 0.01. Immunohistochemical staining of Ihh (f) and MMP-13 (g). Scale bar in f and g = 50 lm lbab/? explants. The area positive for immunostaining for Ihh, one of the markers for chondrogenic differentiation [16] , tended to be a little decreased in lbab/lbab explants compared to that in lbab/? explants, although the intensity of the immunostaining was not different between the two genotypes (Supplemental Fig. 3 ). Immunohistochemical detection of BrdU-incorporated chondrocytes revealed that BrdU-positive chondrocytes tended to be decreased in lbab/lbab explants compared to those in lbab/? explants (Fig. 7d) . Addition of CNP prominently increased the lengths of primordial growth plates (Fig. 7a) and their hypertrophic chondrocyte layers (Fig. 7b, c) of both lbab/? and lbab/lbab explants. The lengths of the primordial growth plate and its hypertrophic chondrocyte layer of lbab/lbab explants treated with 10 -7 M CNP became comparable to those of lbab/? explants treated with the same dose of CNP (Fig. 7a-c) . CNP increased the areas positive for Ihh immunostaining in both lbab/? and lbab/lbab explants. By addition of CNP, the sizes of the areas positive for, and the intensities of, Ihh immunostaining were not different between lbab/? and lbab/ lbab explants (Supplemental Fig. 3 ). CNP did not increase BrdU-positive chondrocytes in lbab/lbab explants (Fig. 7d) .
Further, we explored whether CNP controls the progression of growth plate chondrocytes through the different stages of maturation or not. Because the process of endochondral ossification is delayed in the metatarsus compared to that in the tibia in an individual, we performed organ culture of metatarsi as well as tibiae from fetal mice at 16.5-days postcoitus and examined the expression of type X collagen and Ihh. In the case of lbab/? organ culture, the area positive for immunostaining of type X collagen was reduced and that of Ihh was localized near the ossification center in metatarsal explants compared with those in tibial explants, indicating that the metatarsal growth plate represents an earlier stage of endochondral ossification than the tibial growth plate (Fig. 8) . The area positive for immunostaining of type X collagen was greatly reduced in lbab/lbab metatarsal explants compared with that in lbab/? metatarsal explants and recovered by addition of 10 -7 M CNP to the same extent to that in lbab/? metatarsal explants treated with vehicle. The area positive for immunostaining of Ihh became closer to ossification center Fig. 4 Histological analysis of tibial growth plate from female 10-week-old wild-type (Wt), lbab/lbab, and lbab/lbabÁCNP-Tg mice. a Alcian blue and hematoxylin-eosin staining. Arrows indicate the width of growth plates. Scale bar 50 lm. b Total heights of the growth plates. n = 2-5 each in lbab/lbab metatarsal explants than in lbab/? metatarsal explants and was returned to the same position as lbab/ ? metatarsal explants by addition of CNP (Fig. 8) .
Discussion
Previously, we and other groups had reported in brief communications that the short stature phenotype of lbab/ lbab mice is caused by a mutation in the CNP gene [11] [12] [13] . Here, we further analyzed the skeletal phenotypes of lbab/lbab mice and report the results in this full-length article.
Analysis of the growth curves of nasoanal and nose-tail lengths revealed that the shortness of lbab/lbab mice is mild at birth but rapidly progresses by the age of 3 weeks, and then, after 4 weeks, the ratio of the length of lbab/lbab mice compared to that of wild-type mice becomes almost constant. This suggests that CNP is especially crucial for the skeletal growth spurt that occurs in early life. Since CNP is expressed in the growth plate cartilage and works as an autocrine/paracrine regulator [5] , CNP might affect the endochondral bone growth potently when the volume of growth plate cartilage is relatively abundant.
We confirmed the thinness of the growth plate of lbab/ lbab mice, especially in its hypertrophic chondrocyte layer, followed by the impaired growth of long bones. The thinness of the growth plate of lbab/lbab mice was almost completely recovered by targeted overexpression of CNP in the growth plate by the age of 2 weeks. On the other hand, the recovery of the shortness of the total length of lbab/lbab bones by CNP was only partial at 2 weeks, becoming complete at the age of 10 weeks. This finding suggests that the recovery is evident earlier in the thickness of the growth plate than in the total bone length. In addition, immunohistochemistry for PCNA revealed that at the age of 2 weeks the proliferation of growth plate chondrocytes is decreased in lbab/lbab mice and that the decreased proliferation is not rescued by CNP overexpression, even though the thickness of the growth plate does fully recover. The reason the decreased proliferation of chondrocytes in the lbab/lbab growth plate was not rescued by CNP overexpression in chondrocytes is not clear, but it may be because of the weak and slow expression of the CNP transgene owing to the weak power of the promoter region. On the other hand, CNP could not increase the proliferation of growth plate chondrocytes in lbab/lbab explants in organ culture experiments in this study. The effect of CNP on chondrocyte proliferation might be so mild that other effects of CNP on growth plate chondrocytes, e.g., the stimulatory effect on matrix synthesis as we had previously reported [3, 4] , might proceed to recover the thinned growth plate of lbab/lbab mice. The discrepancy between the effects on proliferation and matrix synthesis may explain in part the delayed recovery of bone length relative to growth plate thickness. On the other hand, immunohistochemical staining of type X collagen and Ihh in explanted growth plates at two different stages of endochondral ossification suggested that the progression of proliferative chondrocytes to hypertrophic chondrocytes was delayed in the lbab/lbab growth plate and recovered by addition of CNP. In addition to the result that the expression of MMP-13 was not different between the terminal hypertrophic chondrocytes of wild-type, lbab/lbab, and rescued growth plates, CNP might promote the hypertrophic differentiation of proliferative chondrocytes but not accelerate the terminal differentiation of hypertrophic chondrocytes.
In this study, we investigated the character of calcified bones of lbab/lbab mice using three-dimensional CT analysis: the bone volume of lbab/lbab mice was substantially decreased compared to that of wild-type mice and recovered by cartilage-specific CNP overexpression. The mechanism of decrease in bone volume of lbab/lbab mice is still unknown, but CNP may be expressed in and affect cells other than chondrocytes, i.e., osteoblasts or osteoclasts, in bone. Although overexpression of CNP was targeted to chondrocytes in our rescue experiments, early onset of CNP-Tg expression from the CP might have been able to affect bone metabolism at the earlier stage of skeletogenesis [17] and may have continued to affect osteoblasts or osteoclasts near the growth plate cartilage in the later stage of skeletogenesis. Whereas several in vitro effects of CNP on osteoblastic cell lineages or osteoclasts have been reported [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] , the in vivo effects of CNP on bone metabolism remain elusive; and further experiments are now ongoing in our laboratory.
We previously discovered that in two strains of mice, cn/cn and slw/slw, dwarfism is caused by spontaneous mutations in the GC-B gene [7, 8] . In humans, it has been identified that AMDM is caused by spontaneous lossof-function mutations in the GC-B gene [9, 29] . The lbab/ lbab mouse, the skeletal phenotype of which we have closely analyzed in the present report, has a spontaneous loss-of-function mutation in the CNP gene; by analogy to the GC-B gene, some forms of human skeletal dysplasia might be caused by mutations in the CNP gene. Thus far, no such conditions have been discovered [30] . In the event such a discovery is made, the lbab/lbab mouse would then be a novel model of a form of human skeletal dysplasia caused by a mutation in the CNP gene.
In contrast to mice homozygous for the lbab allele, the growth and skeletal phenotype of mice heterozygous for the lbab allele were not different from those of wild-type mice, as is the case with heterozygous CNP knockout mice. This confirms that haploinsufficiency for the CNP gene does not exist in mice. Likewise, heterozygotes for the GC-B knockout, the cn allele, or the slw allele exhibit no skeletal abnormalities [6] [7] [8] ; thus, haploinsufficiency of the GC-B gene also does not exist in mice. Nevertheless, haploinsufficiency of the GC-B gene does exist in humans: heterozygous carriers of AMDM are reported to be shorter than expected for their population of origin [31] . The reason for the discrepancy is not clear at present, but it may have to do with differences between species or some other unknown mechanism(s). We will have to perform further investigations on the skeletal phenotypes of the aforementioned lines of GC-B mutant mice; such experiments are now ongoing in our laboratory.
In summary, in this study we more closely investigated the skeletal phenotypes of a novel CNP mutant mouse, lbab/lbab. The results of this study will be useful not only for further elucidation of the physiological role of CNP on endochondral bone growth but also for the prediction of pathophysiology of a hypothetical chondrodysplasia caused by a mutation in the human CNP gene, which has not yet been discovered.
